Locally advanced rectal cancer: The importance of a multidisciplinary approach

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2013) B. Glimelius et al.   ANNALS OF ONCOLOGY

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Phase 2 study of preoperative radiation with concurrent capecitabine, oxaliplatin, and bevacizumab followed by surgery and postoperative 5-fluorouracil, leucovorin, oxaliplatin (FOLFOX), and bevacizumab in patients with locally advanced rectal cancer: ECO

(2013) Jerome C. Landry et al.   CANCER

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

(2012) H. J. Schmoll et al.   ANNALS OF ONCOLOGY

État des lieux du traitement multidisciplinaire du cancer du rectum

(2012) B. De Bari et al.   Cancer Radiotherapie

Complete Response after Neoadjuvant Therapy in Rectal Cancer: To Operate or Not to Operate?

(2012) Georgia Dedemadi et al.   DIGESTIVE DISEASES

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

(2012) Alice Dewdney et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years

(2012) Rolf Sauer et al.   JOURNAL OF CLINICAL ONCOLOGY

Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study

(2011) Doenja M. J. Lambregts et al.   ANNALS OF SURGICAL ONCOLOGY

Biomarkers for Cetuximab-Based Neoadjuvant Radiochemotherapy in Locally Advanced Rectal Cancer

(2011) P. P. Grimminger et al.   CLINICAL CANCER RESEARCH

Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal Cancer

(2011) Monique Maas et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

(2011) Willem van Gijn et al.   LANCET ONCOLOGY

The current landscape of locally advanced rectal cancer

(2011) Mebea Aklilu et al.   Nature Reviews Clinical Oncology

5-fluorouracil pharmacogenomics: still rocking after all these years?

(2011) Mario Scartozzi et al.   PHARMACOGENOMICS

Rectal Cancer: Assessment of Complete Response to Preoperative Combined Radiation Therapy with Chemotherapy—Conventional MR Volumetry versus Diffusion-weighted MR Imaging

(2011) Luís Curvo-Semedo et al.   RADIOLOGY

Patterns of local recurrence in rectal cancer after a multidisciplinary approach

(2011) Jose M Enríquez-Navascués   WORLD JOURNAL OF GASTROENTEROLOGY

KRAS and BRAF Mutations and PTEN Expression Do Not Predict Efficacy of Cetuximab-Based Chemoradiotherapy in Locally Advanced Rectal Cancer

(2010) Philipp Erben et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

(2010) Monique Maas et al.   LANCET ONCOLOGY

Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging

(2010) Ruud G.P.M. van Stiphout et al.   RADIOTHERAPY AND ONCOLOGY

Risk factors for sexual dysfunction after rectal cancer treatment

(2009) M.M. Lange et al.   EUROPEAN JOURNAL OF CANCER

Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)

(2009) Vincenzo Valentini et al.   RADIOTHERAPY AND ONCOLOGY

The diagnosis and management of rectal cancer: expert discussion and recommendations derived from the 9th World Congress on Gastrointestinal Cancer, Barcelona, 2007

(2008) E. Van Cutsem et al.   ANNALS OF ONCOLOGY

Urinary dysfunction after rectal cancer treatment is mainly caused by surgery

(2008) M. M. Lange et al.   BRITISH JOURNAL OF SURGERY